Pfizer shares tumble on weak forecast for 2024 revenues
US drugmaker is trying to chart its future without blockbuster Covid-19 products
US drugmaker is trying to chart its future without blockbuster Covid-19 products
German pharmaceutical company shot to fame as first company to produce a next-generation mRNA vaccine to treat Covid-19
Hospitalisations from Covid-19 have crept up in recent weeks, although the rise is lower than the same time last year
Pfizer’s second-quarter results confirm sharp fall in demand for vaccines and other Covid medicines produced in Ireland
European health officials have advocated portfolio diversity to help fight different variants
Chief executive says draft plan to cut market exclusivity protection could make pursuing some treatments unviable
Sales drop 43% in third quarter as primary immunisation drives reach completion
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs
Group still expects to hit a target of €13-17bn in vaccine revenues this year, with demand increasing in the fourth quarter
Waning demand threatens efforts to produce vaccine locally so perhaps education is the priority
Recommendation comes as global cases of virus top 500m amid Omicron surge
Cantillon: Emerging markets surprise observers with vaccine preferences
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
Another 11,671 PCR-confirmed coronavirus cases reported in past few days
Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages
Companies to test fourth dose of current vaccine against fourth dose of new one
Dr Barney Graham’s discovery was a key step in development of Covid-19 vaccines
In lab tests the drug maintained its antiviral activity against all variants of concern
Drugmakers hope to build on success of Covid vaccine
Next year may bring good news but many of the concerns of 2021 will not have gone away
Next phase of vaccination programme in January complicated by multiple rollouts
More than 1.3 million boosters are given in State so far in race against highly contagious Omicron variant
Data shows no need for variant-specific vaccines, says Biden’s chief medical adviser
Registration for ages five to 11 will open shortly, with priority for those more at risk
Israeli research compared blood samples between two-dose group and booster group
Omicron expected to overtake the dominant Delta variant in the UK ‘by mid-December’
US indices rise as inflation report is in line with expectations
Increased restrictions to contain the Omicron coronavirus variant temper optimism
‘Yo-yo day’ prevails on Dublin stock market
Third vaccine dose as effective as second shot was in fighting original virus, study finds
Total global output will be more than 20 billion shots for the year
New coronavirus variant likely to be more transmissible but less severe, Fauci says
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices